Literature DB >> 8318003

Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.

I T Harvima1, R J Harvima, G Nilsson, L Ivanoff, L B Schwartz.   

Abstract

The V3 loop of the HIV (human immunodeficiency virus)-1 envelope glycoprotein gp120 likely plays a role in HIV-1 infectivity. Although the amino acid sequence of the V3 loop is hypervariable, it contains a conserved region, Gly-Pro-Gly-Arg, that shows similarity to the active-site Gly-Pro-Cys-Arg sequence of inter-alpha-trypsin and trypstatin proteinase inhibitors. The purpose of the present work was to identify proteinases recognizing substrates with basic amino acids in the P1 substrate site that are present in MOLT-4 cells, a human CD4-positive T helper lymphocyte cell line, and to characterize these enzymes in terms of substrate, pH and ionic-strength preferences, size and susceptibility to various inhibitors, including 24- and 36-amino-acid-long V3 loop peptides. Extraction of MOLT-4 cells at low ionic strength solubilized nearly all of the trypsin-like activity, which was separable into five peaks of activity by chromatography on Mono-Q: Peaks 1, 2a, 2b, 3 and 4. All showed a neutral pH optimum, and all except Peak 4 showed optimal activity at high ionic strength. Peak 1 preferred Tos-Gly-Pro-Arg, p-nitroanilide (-pNA) substrate; Peaks 2-4 preferred benzyloxycarbonyl-Val-Leu-Gly-Arg-pNA. Peak 1, a zinc-dependent enzyme with serine and histidine in the active site, exhibited an M(r) of 75,000 on Superose 12 and was poorly inhibited by V3 loop peptides. Peak 2 contained two overlapping peaks, called 2a and 2b, that exhibited properties of zinc-dependent metalloproteinases. Gel filtration of Peak 2 activities revealed a major peak of activity at 81 kDa and a shoulder centred at 240 kDa. Each was modestly inhibited by V3 loop peptides. Peak 3, a zinc-dependent proteinase, exhibited a molecular mass of 100 kDa by gel filtration and was particularly sensitive to inhibition by V3 loop peptides. Peak 4 exhibited a molecular mass of 1100 kDa by gel filtration and was not inhibited by V3 loop peptides. None of these enzymes could be classified as mast-cell tryptase, and material in MOLT-4 cells cross-reactive with anti-(human tryptase) antibodies was not detected. Whether any of the MOLT-4 proteinases described in this study play a role in HIV-1 infectivity remains to be examined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318003      PMCID: PMC1134172          DOI: 10.1042/bj2920711

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.

Authors:  H Kido; A Fukutomi; N Katunuma
Journal:  FEBS Lett       Date:  1991-07-29       Impact factor: 4.124

2.  Retrovirus-induced cell fusion is enhanced by protease treatment.

Authors:  K B Andersen; H Skov
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

3.  CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Authors:  J M Harouse; C Kunsch; H T Hartle; M A Laughlin; J A Hoxie; B Wigdahl; F Gonzalez-Scarano
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells.

Authors:  M Tateno; F Gonzalez-Scarano; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.

Authors:  A M Irani; T R Bradford; C L Kepley; N M Schechter; L B Schwartz
Journal:  J Histochem Cytochem       Date:  1989-10       Impact factor: 2.479

6.  Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection.

Authors:  T Hattori; A Koito; K Takatsuki; H Kido; N Katunuma
Journal:  FEBS Lett       Date:  1989-05-08       Impact factor: 4.124

7.  Towards a better definition of human leucocyte surface molecules.

Authors:  W Knapp; P Rieber; B Dörken; R E Schmidt; H Stein; A E vd Borne
Journal:  Immunol Today       Date:  1989-08

8.  Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.

Authors:  A T Look; R A Ashmun; L H Shapiro; S C Peiper
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

9.  Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity.

Authors:  C V Jongeneel; E J Quackenbush; P Ronco; P Verroust; S Carrel; M Letarte
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

10.  Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.

Authors:  R A Ashmun; A T Look
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

View more
  2 in total

1.  A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.

Authors:  M A Handley; R T Steigbigel; S A Morrison
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 2.  Mast cell proteinases and cytokines in skin inflammation.

Authors:  I T Harvima; L Horsmanheimo; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.